日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/11/14 | 5,498 | 5,515 | 5,388 | 5,480 | -217 | -3.8% | 939,400 |
| 2023/11/13 | 5,700 | 5,816 | 5,677 | 5,697 | -39 | -0.7% | 260,000 |
| 2023/11/10 | 5,786 | 5,830 | 5,717 | 5,736 | -135 | -2.3% | 328,000 |
| 2023/11/09 | 5,914 | 5,954 | 5,794 | 5,871 | -12 | -0.2% | 289,000 |
| 2023/11/08 | 5,786 | 5,949 | 5,777 | 5,883 | +142 | +2.5% | 331,200 |
| 2023/11/07 | 5,839 | 5,885 | 5,741 | 5,741 | -55 | -0.9% | 206,500 |
| 2023/11/06 | 5,980 | 5,995 | 5,770 | 5,796 | -134 | -2.3% | 358,600 |
| 2023/11/02 | 6,017 | 6,023 | 5,841 | 5,930 | -55 | -0.9% | 403,500 |
| 2023/11/01 | 6,091 | 6,102 | 5,928 | 5,985 | -109 | -1.8% | 662,600 |
| 2023/10/31 | 6,222 | 6,241 | 6,004 | 6,094 | +772 | +14.5% | 1,266,900 |
| 2023/10/30 | 5,467 | 5,503 | 5,322 | 5,322 | -179 | -3.3% | 1,025,000 |
| 2023/10/27 | 5,424 | 5,507 | 5,375 | 5,501 | +77 | +1.4% | 194,600 |
| 2023/10/26 | 5,497 | 5,497 | 5,372 | 5,424 | -68 | -1.2% | 358,700 |
| 2023/10/25 | 5,576 | 5,594 | 5,473 | 5,492 | -94 | -1.7% | 257,200 |
| 2023/10/24 | 5,583 | 5,616 | 5,447 | 5,586 | +3 | +0.1% | 237,900 |
| 2023/10/23 | 5,510 | 5,600 | 5,510 | 5,583 | +73 | +1.3% | 232,800 |
| 2023/10/20 | 5,527 | 5,555 | 5,470 | 5,510 | -76 | -1.4% | 283,500 |
| 2023/10/19 | 5,650 | 5,717 | 5,586 | 5,586 | -128 | -2.2% | 206,900 |
| 2023/10/18 | 5,760 | 5,769 | 5,628 | 5,714 | -78 | -1.3% | 256,000 |
| 2023/10/17 | 5,797 | 5,813 | 5,725 | 5,792 | +49 | +0.9% | 214,800 |
| 2023/10/16 | 5,917 | 5,920 | 5,738 | 5,743 | -192 | -3.2% | 263,700 |
| 2023/10/13 | 6,060 | 6,082 | 5,901 | 5,935 | -220 | -3.6% | 362,600 |
| 2023/10/12 | 6,002 | 6,164 | 5,991 | 6,155 | +161 | +2.7% | 240,700 |
| 2023/10/11 | 6,045 | 6,055 | 5,940 | 5,994 | -45 | -0.7% | 205,000 |
| 2023/10/10 | 6,008 | 6,070 | 5,967 | 6,039 | +31 | +0.5% | 274,700 |
| 2023/10/06 | 5,993 | 6,073 | 5,974 | 6,008 | +62 | +1% | 255,600 |
| 2023/10/05 | 5,968 | 5,981 | 5,868 | 5,946 | -51 | -0.9% | 388,300 |
| 2023/10/04 | 6,051 | 6,057 | 5,976 | 5,997 | -143 | -2.3% | 286,000 |
| 2023/10/03 | 6,255 | 6,275 | 6,127 | 6,140 | -104 | -1.7% | 204,000 |
| 2023/10/02 | 6,333 | 6,406 | 6,229 | 6,244 | -85 | -1.3% | 232,500 |
| 2023/09/29 | 6,367 | 6,390 | 6,288 | 6,329 | -38 | -0.6% | 288,900 |
| 2023/09/28 | 6,422 | 6,452 | 6,311 | 6,367 | -147 | -2.3% | 331,300 |
| 2023/09/27 | 6,400 | 6,514 | 6,342 | 6,514 | +111 | +1.7% | 255,100 |
| 2023/09/26 | 6,414 | 6,468 | 6,378 | 6,403 | -15 | -0.2% | 248,000 |
| 2023/09/25 | 6,362 | 6,439 | 6,350 | 6,418 | +83 | +1.3% | 216,200 |
| 2023/09/22 | 6,295 | 6,381 | 6,270 | 6,335 | -23 | -0.4% | 366,500 |
| 2023/09/21 | 6,480 | 6,480 | 6,344 | 6,358 | -145 | -2.2% | 292,800 |
| 2023/09/20 | 6,605 | 6,674 | 6,501 | 6,503 | -144 | -2.2% | 370,400 |
| 2023/09/19 | 6,627 | 6,750 | 6,604 | 6,647 | +6 | +0.1% | 416,800 |
| 2023/09/15 | 6,560 | 6,650 | 6,545 | 6,641 | +29 | +0.4% | 356,700 |
| 2023/09/14 | 6,630 | 6,698 | 6,585 | 6,612 | +11 | +0.2% | 304,700 |
| 2023/09/13 | 6,682 | 6,682 | 6,579 | 6,601 | -46 | -0.7% | 244,000 |
| 2023/09/12 | 6,468 | 6,662 | 6,447 | 6,647 | +183 | +2.8% | 388,200 |
| 2023/09/11 | 6,537 | 6,568 | 6,415 | 6,464 | -85 | -1.3% | 331,200 |
| 2023/09/08 | 6,649 | 6,784 | 6,533 | 6,549 | -76 | -1.1% | 762,500 |
| 2023/09/07 | 6,512 | 6,686 | 6,491 | 6,625 | +149 | +2.3% | 714,400 |
| 2023/09/06 | 6,430 | 6,606 | 6,374 | 6,476 | +146 | +2.3% | 871,000 |
| 2023/09/05 | 6,376 | 6,430 | 6,287 | 6,330 | -107 | -1.7% | 425,800 |
| 2023/09/04 | 6,484 | 6,484 | 6,355 | 6,437 | -17 | -0.3% | 365,900 |
| 2023/09/01 | 6,376 | 6,516 | 6,356 | 6,454 | +55 | +0.9% | 597,200 |
251～
300
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 421,500円 | +5.9% | 0.0% | 2.94% | 9.47倍 | 1.21倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 久光薬 | 428,900円 | +7.3% | -3.8% | 2.10% | 19.91倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ペプチド | 272,400円 | +56.7% | +357.2% | 0.00% | 25.22倍 | 6.00倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 196,100円 | +4.0% | +25.4% | 2.70% | 9.06倍 | 1.19倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 住友ファーマ | 61,500円 | +7.5% | - | 0.00% | - | 2.14倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
市場注目の銘柄
チャート関連のコラム
